FibroGen Inc (NASDAQ:FGEN)

41.49
Delayed Data
As of Sep 13
 -1.06 / -2.49%
Today’s Change
33.51
Today|||52-Week Range
61.95
-10.35%
Year-to-Date

Today’s Trading

Previous close42.55
Today’s open42.79
Day’s range41.00 - 43.22
Volume944,184
Average volume (3 months)752,855
Market cap$3.6B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+40.58%
Earnings growth (this year)+65.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+69.46%
P/E ratio79.8
Price/Sales18.27
Price/Book6.94

Competitors

 Today’s
change
Today’s
% change
MEDPMedpace Holdings Inc+3.73+4.55%
AMRNAmarin Corporation P...-0.04-0.24%
SYNHSyneos Health Inc+0.32+0.59%
EXELExelixis Inc-0.02-0.10%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$213.0M
Annual profit (last year)-$86.4M
Net profit margin-40.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Interim Chief Executive Officer
James A. Schoeneck
CFO, Chief Accounting Officer &
Senior VP-Finance
Pat Cotroneo
Corporate headquarters
San Francisco, California

Forecasts